Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 861177 NEW YORK, NY
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,061,693
+$473,947 QoQ
Shares Held
231,186
-2.5% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 271 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 51% Shared 0% None 49%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. ARQT ranks #55 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in ARQT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,061,693 231,186
2026-03-31 $5,587,746 237,171
2025-12-31 $6,729,553 231,734
2025-09-30 $4,599,681 244,015
2025-06-30 $5,674,396 404,736
2025-03-31 $4,364,294 279,047
2024-12-31 $3,901,790 280,100
2024-09-30 $2,573,225 276,691
2024-06-30 $2,546,144 273,779
2023-09-30 $430,532 81,080
2023-06-30 $568,129 59,615
2023-03-31 $655,765 59,615
2022-12-31 $498,996 33,716
2022-09-30 $365,001 19,100
2022-06-30 $638,702 29,972
2022-03-31 $577,260 29,972
2021-12-31 $621,618 29,972
2021-09-30 $716,030 29,972
2021-06-30 $817,935 29,972
2021-03-31 $613,316 21,200